Skip to content

Tectonic Therapeutics TECX Change in Lease Liabilities

Change in Lease Liabilities at other companies

Septerna, Inc. logo
Septerna, Inc.SEPN
-$535K-18.9%
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
-$236K+89.5%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
-$5M-4.3%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
-$145K-114%
Ethos Technologies, Inc.
 logo
Ethos Technologies, Inc. LIFE
-$191K-17.9%
Precigen logo
PrecigenPGEN
-$75K+21.1%

Other financials

Income statement

See full
Operating income-$27.3M-49.2%
Net income-$25.2M-58.7%
EPS (diluted)-$1.34-44.1%

Balance sheet

See full
Cash & equivalents$236.9M-22.8%
Total debt$4.9M+86.1%
Total equity$230.4M-23.5%
Total assets$246.6M-21.7%

Cash flow

See full
Operating cash flow-$18.4M-40.7%
CapEx$19.0K-29.6%
Free cash flow-$18.4M-40.6%

Valuation

See full
Market cap$585.51M+58.3%
Enterprise value$353.51M+438%

Returns & leverage

See full
Return on equity-31.4%
Debt / equity0.0×
Current ratio18.5×-4.4×

Where this comes from

Reported directly by Tectonic Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.

The official record: Tectonic Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tectonic Therapeutics's change in lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tectonic Therapeutics's change in lease liabilities?
Tectonic Therapeutics (TECX) reported change in lease liabilities of -$147K in Q1 2026.
How has Tectonic Therapeutics's change in lease liabilities changed year-over-year?
Tectonic Therapeutics's change in lease liabilities increased by 73.4% year-over-year, from -$553K to -$147K.
What does change in lease liabilities mean?
Cash payments for operating leases reducing the lease liability, partially offset by new lease commencements.